Improving skin self-examination for melanoma survivors using a digital tool
A digital intervention to improve skin self-examination among melanoma survivors
This study is testing a new digital tool called mySmartSkin to help melanoma survivors do better skin checks at home, and it’s all about making sure the tool works well and is easy for everyone to use.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11052633 on NIH RePORTER |
What this research studies
This research focuses on enhancing skin self-examination (SSE) practices among melanoma survivors through a digital intervention called mySmartSkin (MSS). The study aims to improve the effectiveness of MSS by engaging various stakeholders to refine the tool based on their feedback. By utilizing a hybrid effectiveness-implementation trial design, the research will assess how well the enhanced MSS works and identify factors that facilitate its widespread use. This approach is crucial as many melanoma survivors do not regularly perform SSE, which is vital for early detection of recurrences.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have survived melanoma and are at risk for recurrence or new primary cancers.
Not a fit: Patients who are not melanoma survivors or those who do not have access to digital tools may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the rate of early melanoma detection among survivors, potentially improving their long-term health outcomes.
How similar studies have performed: Previous research has shown promising results with digital interventions aimed at improving health behaviors, suggesting that this approach could be effective.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Manne, Sharon L — Rutgers Biomedical and Health Sciences
- Study coordinator: Manne, Sharon L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.